Literature DB >> 19627538

Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage.

Uta Drebber1, Juliane J M Mueller, Ellen Klein, Hans U Kasper, Falko Schulze, Katharina Schardt, Maria Quasdorff, Sigrid Schulte, Margarete Odenthal, Hans P Dienes.   

Abstract

The purpose of the present study was to characterize histopathological lesions in primary biliary cirrhosis (PBC) and to assess the relationship between histopathological lesions and biochemistry. Liver biopsies of 252 patients with PBC were investigated. A laboratory database was established. Histopathological characterization was performed. Relationships between detailed histopathological features and biochemistry were calculated statistically. Combining the data, a PBC group, consisting of an anti-mitochondrial antibody (AMA)-positive and -negative subgroup, and an overlap group were defined, with a female preponderance of >90% and higher activity of aspartate aminotransferase (AST) in the overlap group. Histopathological changes were characteristic in >80%. Periductal concentric fibrosis, lobular granuloma formation and steatosis were frequently remarkable. Correlations were found between alanine aminotransferase activity and modified hepatitis activity index in the overlap group and the AMA-positive group. A positive significant relationship was demonstrated between mean AST activity and portal fibrosis for the AMA-positive group. A highly significant positive link was seen between mean concentration of bilirubin and stage of fibrosis. Biochemistry reflects only in part the degree of severity of histopathological lesions in PBC. Histopathology indicates comorbidity in a high percentage of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627538     DOI: 10.1111/j.1440-1827.2009.02405.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  The immunopathology of liver granulomas in primary biliary cirrhosis.

Authors:  Zhengrui You; Qixia Wang; Zhaolian Bian; Yuan Liu; Xiaofeng Han; Yanshen Peng; Lei Shen; Xiaoyu Chen; Dekai Qiu; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2012-06-23       Impact factor: 7.094

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis.

Authors:  Ourania Sfakianaki; Maria Tzardi; Argyro Voumvouraki; Aikaterini Afgoustaki; Meri Koulentaki; Elias Kouroumalis
Journal:  World J Hepatol       Date:  2013-10-27

Review 4.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

5.  Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Li-Na Zhang; Hua Chen; Li Wang; Min Shen; Xuan Zhang; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

6.  Tubulointerstitial nephritis associated with primary biliary cirrhosis.

Authors:  Mohammad-Hosein Rasolzadegan; Hanie Bakhshayesh; Nakisa Amid
Journal:  J Nephropharmacol       Date:  2014-07-01

7.  Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?

Authors:  Gerald Y Minuk; Galia Pollock; Julia Uhanova
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.